|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.430 AUD | -1.04% |
|
+16.26% | -13.60% |
| Capitalization | 1.42B 1.03B 879M 804M 761M 1.41B 98.15B 9.6B 3.73B 46.64B 3.85B 3.77B 162B | P/E ratio 2026 * |
-19.5x | P/E ratio 2027 * | -13.6x |
|---|---|---|---|---|---|
| Enterprise value | 754M 544M 466M 426M 404M 748M 52.06B 5.09B 1.98B 24.74B 2.04B 2B 86.1B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
75.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PYC Therapeutics Limited
| 17/03 | Bell Potter rates PYC as Speculative Buy | AQ |
| 09/09/25 | Bell Potter rates PYC as Speculative Buy | AQ |
| 07/11/24 | PYC Therapeutics : Anti Bribery & Anti Corruption Policy | PU |
| 07/11/24 | PYC Therapeutics : Definition of Independence | PU |
| 07/11/24 | PYC Therapeutics : Continuous Disclosure Policy | PU |
| 1 day | -1.04% | ||
| 1 week | +16.26% | ||
| Current month | +13.49% | ||
| 1 month | +18.18% | ||
| 3 months | -4.98% | ||
| 6 months | +10.00% | ||
| Current year | -13.60% |
| 1 week | 1.19 |  | 1.48 |
| 1 month | 1.14 | | 1.48 |
| Current year | 1.04 | | 1.76 |
| 1 year | 0.85 | | 1.76 |
| 3 years | 0.5 | | 2.1 |
| 5 years | 0.5 | | 2.1 |
| 10 years | 0.12 | | 2.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 42 | 19/08/2020 |
Sri Mudumba
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paula Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
BRD | Director/Board Member | 42 | 30/11/2018 |
Ian Constable
BRD | Director/Board Member | - | 22/09/2025 |
Peter Coleman
CHM | Chairman | 66 | 18/11/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.04% | +16.26% | +16.26% | +113.43% | 1.03B | |
| -0.47% | -2.42% | -16.79% | -19.35% | 42.28B | |
| -3.77% | -3.91% | +38.50% | +27.79% | 33.87B | |
| -0.31% | +4.88% | +278.60% | +477.77% | 31.78B | |
| -0.99% | -4.46% | +20.35% | -9.30% | 28.49B | |
| +2.41% | -3.65% | +31.50% | +27.88% | 27.41B | |
| +0.78% | -0.26% | - | - | 15.25B | |
| -1.50% | -14.49% | +198.14% | +4,123.83% | 13.31B | |
| -2.47% | -0.45% | +132.15% | +113.12% | 12.51B | |
| -0.91% | -0.84% | +5.90% | -2.74% | 12.2B | |
| Average | -0.83% | -0.24% | +78.29% | +539.16% | 21.81B | |
| Weighted average by Cap. | -0.79% | -2.30% | +75.26% | +355.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -61.32M -44.29M -37.94M -34.69M -32.85M -60.82M -4.23B -414M -161M -2.01B -166M -163M -7B | -91.46M -66.07M -56.6M -51.75M -49.01M -90.73M -6.32B -618M -240M -3B -248M -243M -10.45B |
| Net Debt | -667M -482M -413M -378M -358M -662M -46.1B -4.51B -1.75B -21.9B -1.81B -1.77B -76.24B | -584M -422M -362M -331M -313M -580M -40.36B -3.95B -1.53B -19.18B -1.58B -1.55B -66.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 1.430 $ | -1.04% | 950,858 |
| 14/05/26 | 1.445 $ | +0.35% | 2,078,574 |
| 13/05/26 | 1.440 $ | +7.87% | 2,757,062 |
| 12/05/26 | 1.335 $ | +5.53% | 10,532,850 |
| 11/05/26 | 1.265 $ | +2.85% | 1,111,359 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PYC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition